Search research articles
Contact Us
Filters
Showing results (21-30 of 76) with videos related to
Page
of 8
Sort By:
Frontiers in Oncology
|
May 17, 2021
TERT-Promoter Mutational Status in Glioblastoma - Is There an Association With Amino Acid Uptake on Dynamic <sup>18</sup>F-FET PET?
Marcus Unterrainer, Viktoria Ruf, Katharina von Rohr, et al.
Cancers
|
May 14, 2025
Comparison of the Hematotoxicity of PRRT with Lutathera<sup>®</sup> and Locally Manufactured <sup>177</sup>Lu-HA-DOTATATE in Patients with Neuroendocrine Tumors and the Impact of Different Application Intervals
Markus Hofmann, Sophie C Kunte, Marcus Unterrainer, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
January 12, 2023
Cost-Effectiveness Analysis of 177Lu-PSMA-617 Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer
Dirk Mehrens, Kristina K M Kramer, Lena M Unterrainer, et al.
Neuroimage
|
January 8, 2024
Validity and value of metabolic connectivity in mouse models of β-amyloid and tauopathy
François Ruch, Johannes Gnörich, Karin Wind, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
October 10, 2021
Outcome after PSMA-PET/CT-based salvage radiotherapy for nodal recurrence after radical prostatectomy
Paul Rogowski, Christian Trapp, Rieke von Bestenbostel, et al.
Diagnostics (Basel, Switzerland)
|
April 3, 2021
Correlation of an Index-Lesion-Based SPECT Dosimetry Method with Mean Tumor Dose and Clinical Outcome after <sup>177</sup>Lu-PSMA-617 Radioligand Therapy
Friederike Völter, Lena Mittlmeier, Astrid Gosewisch, et al.
Neuroimage. Clinical
|
April 27, 2025
Partial volume effect correction impairs the diagnostic utility of [<sup>18</sup>F]-THK-5351 PET in nonfluent-agrammatic variant primary progressive aphasia
Patrick J Sommer, Sebastian Schuster, Oliver Goldhardt, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
January 11, 2023
Biodistribution and dosimetry for combined [<sup>177</sup>Lu]Lu-PSMA-I&T/[<sup>225</sup>Ac]Ac-PSMA-I&T therapy using multi-isotope quantitative SPECT imaging
Astrid Delker, Mirjam Schleske, Grigory Liubchenko, et al.
Frontiers in Neurology
|
July 6, 2018
Clinical Routine FDG-PET Imaging of Suspected Progressive Supranuclear Palsy and Corticobasal Degeneration: A Gatekeeper for Subsequent Tau-PET Imaging?
Leonie Beyer, Johanna Meyer-Wilmes, Sonja Schönecker, et al.
Neuroimage. Clinical
|
August 10, 2019
Neuronal injury biomarkers for assessment of the individual cognitive reserve in clinically suspected Alzheimer's disease
Leonie Beyer, Jonas Schnabel, Philipp Kazmierczak, et al.
Page
of 8
Search research articles
Search
Showing results (21-30 of 76) with videos related to
Sort By:
Page
of 8
Frontiers in Oncology
|
May 17, 2021
TERT-Promoter Mutational Status in Glioblastoma - Is There an Association With Amino Acid Uptake on Dynamic <sup>18</sup>F-FET PET?
Marcus Unterrainer, Viktoria Ruf, Katharina von Rohr, et al.
Cancers
|
May 14, 2025
Comparison of the Hematotoxicity of PRRT with Lutathera<sup>®</sup> and Locally Manufactured <sup>177</sup>Lu-HA-DOTATATE in Patients with Neuroendocrine Tumors and the Impact of Different Application Intervals
Markus Hofmann, Sophie C Kunte, Marcus Unterrainer, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
January 12, 2023
Cost-Effectiveness Analysis of 177Lu-PSMA-617 Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer
Dirk Mehrens, Kristina K M Kramer, Lena M Unterrainer, et al.
Neuroimage
|
January 8, 2024
Validity and value of metabolic connectivity in mouse models of β-amyloid and tauopathy
François Ruch, Johannes Gnörich, Karin Wind, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
October 10, 2021
Outcome after PSMA-PET/CT-based salvage radiotherapy for nodal recurrence after radical prostatectomy
Paul Rogowski, Christian Trapp, Rieke von Bestenbostel, et al.
Diagnostics (Basel, Switzerland)
|
April 3, 2021
Correlation of an Index-Lesion-Based SPECT Dosimetry Method with Mean Tumor Dose and Clinical Outcome after <sup>177</sup>Lu-PSMA-617 Radioligand Therapy
Friederike Völter, Lena Mittlmeier, Astrid Gosewisch, et al.
Neuroimage. Clinical
|
April 27, 2025
Partial volume effect correction impairs the diagnostic utility of [<sup>18</sup>F]-THK-5351 PET in nonfluent-agrammatic variant primary progressive aphasia
Patrick J Sommer, Sebastian Schuster, Oliver Goldhardt, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
January 11, 2023
Biodistribution and dosimetry for combined [<sup>177</sup>Lu]Lu-PSMA-I&T/[<sup>225</sup>Ac]Ac-PSMA-I&T therapy using multi-isotope quantitative SPECT imaging
Astrid Delker, Mirjam Schleske, Grigory Liubchenko, et al.
Frontiers in Neurology
|
July 6, 2018
Clinical Routine FDG-PET Imaging of Suspected Progressive Supranuclear Palsy and Corticobasal Degeneration: A Gatekeeper for Subsequent Tau-PET Imaging?
Leonie Beyer, Johanna Meyer-Wilmes, Sonja Schönecker, et al.
Neuroimage. Clinical
|
August 10, 2019
Neuronal injury biomarkers for assessment of the individual cognitive reserve in clinically suspected Alzheimer's disease
Leonie Beyer, Jonas Schnabel, Philipp Kazmierczak, et al.
Page
of 8